Artigo Acesso aberto Revisado por pares

No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial

2013; Oxford University Press; Volume: 53; Issue: 4 Linguagem: Inglês

10.1093/rheumatology/ket426

ISSN

1462-0332

Autores

René Panduro Poggenborg, Charlotte Wiell, Pernille Bøyesen, Annelies Boonen, Paul Bird, Susanne Juhl Pedersen, IJ Sørensen, Ole Rintek Madsen, Ole Slot, J. Møller, Maria Hasselquist, Olga Kubassova, Mikkel Østergaard,

Tópico(s)

Rheumatoid Arthritis Research and Therapies

Resumo

Objective. In a comparative conventional MRI, dynamic contrast-enhanced (DCE)-MRI, CT and radiography study, the authors aimed to monitor whether inflammation is reduced or even eliminated and damage halted in PsA patients receiving anti-TNF therapy.

Referência(s)
Altmetric
PlumX